Advertisement
Screener

INNOVUS PHARMACEUTICALS, INC. Deferred Costs, Current

INNOVUS PHARMACEUTICALS, INC. Deferred Costs, Current

INNOVUS PHARMACEUTICALS, INC. had Deferred Costs, Current of $134.76 thousand as of 2015-09-30, per its 10-Q filed 2015-11-16.

Discontinued › Balance Sheet › Assets › Assets, Current

us-gaap:DeferredCostsCurrent · last filed 2015-11-16

  • 2015-09-30: Deferred Costs, Current $134.76K.
Period endDeferred Costs, Current
2015-09-30$134.76K
10-Q · filed 2015-11-16